Why do we need to worry about antimicrobial resistance in the time of COVID-19?
19 June 2020
The world is struggling hard to control the COVID-19 pandemic. This is difficult as the disease is new and we do not have specific drugs and vaccines to treat it or create immunity against it. What we have in our arsenal are the existing broad-spectrum antimicrobials.
Further reading: Down to Earth
Author(s): Vibha Varshney
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
